Abstract:Adenylate Kinase (AK) is a signal transducing protein that regulates cellular energy homeostasis balancing between different conformations. An alteration of its activity can lead to severe pathologies such as heart failure, cancer and neurodegenerative diseases. A comprehensive elucidation of the large-scale conformational motions that rule the functional mechanism of this enzyme is of great value to guide rationally the development of new medications. Here using a metadynamics-based computational protocol we … Show more
“…This is also supported by NMR studies on single substrate binding to ADK (42). Previous MD simulation studies that were either based on an implicit solvation model (26) or performed in explicit solvent also predicted a significant penalty for complete closing in the apo form (22,30). The simulations on holo ADK suggest that opening of the ATP-lid is the most likely first step in the release of the substrates (or products), as the free-energy landscape indicates a higher mobility of the ATP-lid compared to the AMP-lid in the holo form.…”
Section: Discussionmentioning
confidence: 53%
“…Alternatively, coarse-grained models allow more extensive sampling (20), but the accuracy of such models and the implicit treatment of the solvent may not be sufficient to analyze the influence of different substrates on the dynamics of ADK. More recently, progress has been made by employing advanced sampling methods in atomistic MD simulations on ADK (25)(26)(27)(28)(29)(30). Significant contributions have emerged from these studies, but as they focused on ADK in the apo state or bound to an inhibitor, the dynamics in the presence of natural substrates have not been covered.…”
The enzyme adenylate kinase (ADK) features two substrate binding domains that undergo large-scale motions during catalysis. In the apo state, the enzyme preferentially adopts a globally open state with accessible binding sites. Binding of two substrate molecules (AMP + ATP or ADP + ADP) results in a closed domain conformation, allowing efficient phosphoryl-transfer catalysis. We employed molecular dynamics simulations to systematically investigate how the individual domain motions are modulated by the binding of substrates. Two-dimensional free-energy landscapes were calculated along the opening of the two flexible lid domains for apo and holo ADK as well as for all single natural substrates bound to one of the two binding sites of ADK. The simulations reveal a strong dependence of the conformational ensembles on type and binding position of the bound substrates and a nonsymmetric behavior of the lid domains. Altogether, the ensembles suggest that, upon initial substrate binding to the corresponding lid site, the opposing lid is maintained open and accessible for subsequent substrate binding. In contrast, ATP binding to the AMP-lid induces global domain closing, preventing further substrate binding to the ATP-lid site. This might constitute a mechanism by which the enzyme avoids the formation of a stable but enzymatically unproductive state.
“…This is also supported by NMR studies on single substrate binding to ADK (42). Previous MD simulation studies that were either based on an implicit solvation model (26) or performed in explicit solvent also predicted a significant penalty for complete closing in the apo form (22,30). The simulations on holo ADK suggest that opening of the ATP-lid is the most likely first step in the release of the substrates (or products), as the free-energy landscape indicates a higher mobility of the ATP-lid compared to the AMP-lid in the holo form.…”
Section: Discussionmentioning
confidence: 53%
“…Alternatively, coarse-grained models allow more extensive sampling (20), but the accuracy of such models and the implicit treatment of the solvent may not be sufficient to analyze the influence of different substrates on the dynamics of ADK. More recently, progress has been made by employing advanced sampling methods in atomistic MD simulations on ADK (25)(26)(27)(28)(29)(30). Significant contributions have emerged from these studies, but as they focused on ADK in the apo state or bound to an inhibitor, the dynamics in the presence of natural substrates have not been covered.…”
The enzyme adenylate kinase (ADK) features two substrate binding domains that undergo large-scale motions during catalysis. In the apo state, the enzyme preferentially adopts a globally open state with accessible binding sites. Binding of two substrate molecules (AMP + ATP or ADP + ADP) results in a closed domain conformation, allowing efficient phosphoryl-transfer catalysis. We employed molecular dynamics simulations to systematically investigate how the individual domain motions are modulated by the binding of substrates. Two-dimensional free-energy landscapes were calculated along the opening of the two flexible lid domains for apo and holo ADK as well as for all single natural substrates bound to one of the two binding sites of ADK. The simulations reveal a strong dependence of the conformational ensembles on type and binding position of the bound substrates and a nonsymmetric behavior of the lid domains. Altogether, the ensembles suggest that, upon initial substrate binding to the corresponding lid site, the opposing lid is maintained open and accessible for subsequent substrate binding. In contrast, ATP binding to the AMP-lid induces global domain closing, preventing further substrate binding to the ATP-lid site. This might constitute a mechanism by which the enzyme avoids the formation of a stable but enzymatically unproductive state.
“…The conformational spaces of different NMPKs like AMK, GMK, and UMK have been explored using several approaches like NMR, X-ray crystallography, and molecular dynamics simulations. These studies depicted the presence of considerable interdomain movements [9][10][11][12] during different steps of catalysis like substrate binding, phosphoryl transfer, product formation, and product release. An in-depth understanding of the catalytic steps at the molecular level is very useful in designing potent inhibitors for these enzymes.…”
“…Accordingly, several studies aimed at understanding resistance mutations in kinases, including ALK, Abl1, KIT, and EGFR . Many other studies applied MD simulations for a better understanding of the dynamics, diversity, and thermodynamics of kinases, their activation process, allostery, or in the process of drug design . A homology model of FLT3 was used to infer on the binding of certain drugs through computational docking …”
Fms-like tyrosine kinase 3 (FLT3) is a receptor tyrosine kinase that is a drug target for leukemias. Several potent inhibitors of FLT3 exist, and bind to the inactive form of the enzyme. Unfortunately, resistance due to mutations in the kinase domain of FLT3 limits the therapeutic effects of these inhibitors. As in many other cases, it is not straightforward to explain why certain mutations lead to drug resistance. Extensive fully atomistic molecular dynamics (MD) simulations of FLT3 were carried out with an inhibited form (FLT-quizartinib complex), a free (apo) form, and an active conformation. In all cases, both the wild type (wt) proteins and two resistant mutants (D835F and Y842H) were studied. Analysis of the simulations revealed that impairment of protein-drug interactions cannot explain the resistance mutations in question. Rather, it appears that the active state of the mutant forms is perturbed by the mutations. It is therefore likely that perturbation of deactivation of the protein (which is necessary for drug binding) is responsible for the reduced affinity of the drug to the mutants. Importantly, this study suggests that it is possible to explain the source of resistance by mutations in FLT3 by an analysis of unbiased MD simulations.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.